SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
AdvanSix Inc. (ASIX) trades at a trailing P/E of 13.3, forward P/E of 15.3. Trailing earnings yield is 7.50%, forward earnings yield 6.54%. PEG 1.20. Graham Number is $35.29.
Criteria proven by this page:
- VALUE (76/100, Pass) — P/E is below market average (13.3); earnings yield beats bond yields (7.50%).
- PEG Ratio 1.20 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 7.50% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
- Analyst consensus target $22.00 (-5.6% downside) — slight downside risk — the market may be ahead of analyst expectations.
Overall SharesGrow Score: 53/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
76/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ASIX
Valuation Multiples
P/E (TTM)13.3
Forward P/E15.3
PEG Ratio1.20
Forward PEG0.18
P/B Ratio0.81
P/S Ratio0.43
EV/EBITDA7.0
Per Share Data
EPS (TTM)$1.83
Forward EPS (Est.)$1.53
Book Value / Share$30.26
Revenue / Share$56.50
FCF / Share$0.24
Yields & Fair Value
Earnings Yield7.50%
Forward Earnings Yield6.54%
Dividend Yield2.62%
Graham Number$35.29
SharesGrow IV$100.80 (+332.4%)
Analyst Target$22.00 (-5.6%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
19.8 |
-0.43 |
3.13 |
0.57 |
39.91% |
| 2017 |
8.7 |
0.03 |
3.41 |
0.87 |
- |
| 2018 |
11.1 |
-0.20 |
1.75 |
0.48 |
- |
| 2019 |
13.6 |
-0.41 |
1.40 |
0.43 |
- |
| 2020 |
12.2 |
1.05 |
1.26 |
0.48 |
- |
| 2021 |
9.5 |
0.05 |
2.21 |
0.79 |
0.26% |
| 2022 |
6.2 |
0.26 |
1.44 |
0.55 |
1.42% |
| 2023 |
15.0 |
-0.22 |
1.11 |
0.53 |
2.04% |
| 2024 |
17.3 |
-0.99 |
0.99 |
0.50 |
2.24% |
| 2025 |
9.4 |
0.87 |
0.57 |
0.31 |
3.69% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.12 |
$1.19B |
$34.15M |
2.9% |
| 2017 |
$4.72 |
$1.48B |
$146.7M |
9.9% |
| 2018 |
$2.14 |
$1.51B |
$66.24M |
4.4% |
| 2019 |
$1.43 |
$1.3B |
$41.35M |
3.2% |
| 2020 |
$1.64 |
$1.16B |
$46.08M |
4% |
| 2021 |
$4.81 |
$1.68B |
$139.79M |
8.3% |
| 2022 |
$5.92 |
$1.95B |
$171.89M |
8.8% |
| 2023 |
$1.95 |
$1.53B |
$54.62M |
3.6% |
| 2024 |
$1.62 |
$1.52B |
$44.15M |
2.9% |
| 2025 |
$1.80 |
$1.52B |
$49.29M |
3.2% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$1.53 |
$1.30 – $1.75 |
$1.55B |
$1.55B – $1.56B |
1 |
| 2027 |
$2.84 |
$2.58 – $3.10 |
$1.63B |
$1.6B – $1.66B |
1 |
